Results 101 to 110 of about 32,071 (158)

Efficacy and safety of remdesivir and favipiravir in COVID-19 patients - A systematic review and meta-analysis. [PDF]

open access: yesJ Family Med Prim Care
Vatsha P   +5 more
europepmc   +1 more source

REMDESIVIR CAUSING PROFOUND BRADYCARDIA

open access: yesJournal of the American College of Cardiology, 2021
Saif Aldeen Al-Adwan   +3 more
openaire   +2 more sources

Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir. [PDF]

open access: yesInfect Dis Rep
Gupta K   +6 more
europepmc   +1 more source

Intravenous Administration of Remdesivir at the Acute Phase of SARS-CoV-2 Infection Is Associated with a Lower Prevalence of Post-COVID-19 Pain. [PDF]

open access: yesJ Clin Med
Fernández-de-Las-Peñas C   +10 more
europepmc   +1 more source

Population Pharmacokinetic Modelling of Remdesivir and Its Metabolite GS-441524 in Hospitalised Patients with COVID-19. [PDF]

open access: yesClin Pharmacokinet
Roberts DM   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy